TORONTO, Jan. 21, 2014 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today provided a progress update on the commercial operations of its recently formed joint venture, Innovative Diagnostic Laboratory LLP (“IDL”), including the full-scale rollout of the ColonSentry® test throughout the United States and the addition of EarlyCDT®-Lung - a simple blood test that aids physicians in risk assessment and the early detection of lung cancer in high-risk, asymptomatic patients – to IDL’s offering.
Help employers find you! Check out all the jobs and post your resume.